Cargando…
Las arritmias en la amiloidosis cardiaca
Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationshi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Nacional Cardiovascular - INCOR
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284580/ https://www.ncbi.nlm.nih.gov/pubmed/37351307 http://dx.doi.org/10.47487/apcyccv.v3i2.217 |
_version_ | 1785061433677971456 |
---|---|
author | Salinas-Arce, Jorge Alca-Clares, Raúl Gonzales-Luna, Ana Cecilia Cabrera-Saldaña, Mario Mendoza-Novoa, Pablo Solórzano-Altamirano, Paula Guevara-Valdivia, Milton |
author_facet | Salinas-Arce, Jorge Alca-Clares, Raúl Gonzales-Luna, Ana Cecilia Cabrera-Saldaña, Mario Mendoza-Novoa, Pablo Solórzano-Altamirano, Paula Guevara-Valdivia, Milton |
author_sort | Salinas-Arce, Jorge |
collection | PubMed |
description | Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is specially related to different kinds of arrhythmias even in pre-diagnosis stages. Arrhythmias like atrial fibrillation are present in up to 70% of patients with CA associated with a high risk of cardioembolic complications independent of the risk stratification. Ventricular arrhythmias are frequent, but the use of implantable cardioverter defibrillator has not been demonstrated to improve survival. The Atrial-Ventricular node disease is also common, and is frequently associated with the implantation of a pacemaker, even in asymptomatic patients. In this review, we clarify the recommendations of the most current guidelines, summarize historical and contemporaneous data and describe evidence-based strategies for the management of arrhythmias and their complications in CA. |
format | Online Article Text |
id | pubmed-10284580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Instituto Nacional Cardiovascular - INCOR |
record_format | MEDLINE/PubMed |
spelling | pubmed-102845802023-06-22 Las arritmias en la amiloidosis cardiaca Salinas-Arce, Jorge Alca-Clares, Raúl Gonzales-Luna, Ana Cecilia Cabrera-Saldaña, Mario Mendoza-Novoa, Pablo Solórzano-Altamirano, Paula Guevara-Valdivia, Milton Arch Peru Cardiol Cir Cardiovasc Artículo De Revisión Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is specially related to different kinds of arrhythmias even in pre-diagnosis stages. Arrhythmias like atrial fibrillation are present in up to 70% of patients with CA associated with a high risk of cardioembolic complications independent of the risk stratification. Ventricular arrhythmias are frequent, but the use of implantable cardioverter defibrillator has not been demonstrated to improve survival. The Atrial-Ventricular node disease is also common, and is frequently associated with the implantation of a pacemaker, even in asymptomatic patients. In this review, we clarify the recommendations of the most current guidelines, summarize historical and contemporaneous data and describe evidence-based strategies for the management of arrhythmias and their complications in CA. Instituto Nacional Cardiovascular - INCOR 2022-06-27 /pmc/articles/PMC10284580/ /pubmed/37351307 http://dx.doi.org/10.47487/apcyccv.v3i2.217 Text en https://creativecommons.org/licenses/by-nc/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons |
spellingShingle | Artículo De Revisión Salinas-Arce, Jorge Alca-Clares, Raúl Gonzales-Luna, Ana Cecilia Cabrera-Saldaña, Mario Mendoza-Novoa, Pablo Solórzano-Altamirano, Paula Guevara-Valdivia, Milton Las arritmias en la amiloidosis cardiaca |
title | Las arritmias en la amiloidosis cardiaca |
title_full | Las arritmias en la amiloidosis cardiaca |
title_fullStr | Las arritmias en la amiloidosis cardiaca |
title_full_unstemmed | Las arritmias en la amiloidosis cardiaca |
title_short | Las arritmias en la amiloidosis cardiaca |
title_sort | las arritmias en la amiloidosis cardiaca |
topic | Artículo De Revisión |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284580/ https://www.ncbi.nlm.nih.gov/pubmed/37351307 http://dx.doi.org/10.47487/apcyccv.v3i2.217 |
work_keys_str_mv | AT salinasarcejorge lasarritmiasenlaamiloidosiscardiaca AT alcaclaresraul lasarritmiasenlaamiloidosiscardiaca AT gonzaleslunaanacecilia lasarritmiasenlaamiloidosiscardiaca AT cabrerasaldanamario lasarritmiasenlaamiloidosiscardiaca AT mendozanovoapablo lasarritmiasenlaamiloidosiscardiaca AT solorzanoaltamiranopaula lasarritmiasenlaamiloidosiscardiaca AT guevaravaldiviamilton lasarritmiasenlaamiloidosiscardiaca |